Observational studyBMC anesthesiology2026
The use of sugammadex and quantitative neuromuscular monitoring to facilitate fast-track liver transplantation: an observational study.
Observational study in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundFast-track anesthesia protocols for liver transplantation are becoming more common as institutions strive to innovate and advance perioperative care. However, patients with end-stage liver disease present unique challenges to medication management due to altered pharmacokinetics and pharmacodynamics. The current study was designed to investigate the role of sugammadex administration guided by quantitative neuromuscular monitoring and its impact on postoperative outcomes in patients undergoing fast-track anesthesia protocols for liver transplantation.
methodsConsenting patients undergoing liver transplantation were enrolled in this observational, descriptive study. Prior to induction of general anesthesia, an electromyographic neuromuscular device (TetraGraph, Senzime AB, Uppsala, Sweden) was placed to monitor the adductor pollicis muscle. Anesthetic management was at the discretion of the attending anesthesiologist and included the use of rocuronium to establish and maintain neuromuscular block. At the conclusion of the operation, sugammadex was administered to restore neuromuscular function based on electromyographic measurements recorded every 20 s until tracheal extubation. Neuromuscular function was measured upon arrival to the recovery room, then 5 min and 10 min after arrival. Postoperative outcomes (pulmonary complications, delirium) were extracted from the medical records.
resultsForty-five patients were enrolled and 30 completed the study. Seven patients had not fully recovered neuromuscular function at the time of tracheal extubation, and two patients had residual neuromuscular block upon arrival to the recovery room. After 10 min in the recovery room, one of these patients had recovered neuromuscular function (train-of-four ratio, TOFR > 0.90), while the other patient required additional sugammadex. Two patients required admission to the intensive care unit; no patients experienced postoperative pulmonary complications or delirium during the first 30 postoperative days.
conclusionsWhile the use of sugammadex did not eliminate the incidence of residual neuromuscular block, it is a feasible option when guided by quantitative monitoring to facilitate fast-track anesthesia for liver transplantation and avoid admission to the intensive care unit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.